About ECMO Devices
ECMO stands for extracorporeal membrane oxygenation. It is available in three types such as VV ECMO, VA ECMO, and AV ECMO. Veno-Arterial ECMO System is a machine treatment which is used in patients who are suffering from cardiogenic shock or cardiopulmonary failure. This machine treatment is widely used for patients undergoing a lung transplant or heart transplant. Respiratory, Cardiology and others are some of the major applications of the Veno-Arterial ECMO System. The VA ECMO is connected to both a vein and an artery. Growing incidences of chronic obstructive pulmonary disorder (COPD), and surging prevalence of cardiopulmonary diseases, which is likely to lead to rising demand for ECMO devices. For instance, in 2013, as per an article published by the American Lung Association (ALA), COPD is the third leading cause of death in the United States. In addition, above 11 million people have been diagnosed with COPD. Hence, this has led to witness the growth of the global ECMO devices market during the forecast period.
Attributes | Details |
---|
Study Period | 2018-2029 |
Base Year | 2023 |
High Growth Market | Asia-Pacific |
Unit | Value (USD Million) |
The global ECMO Devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global ECMO Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Medtronic Plc (United States), Getinge AB (Sweden), LivaNova PLC (United Kingdom), XENIOS AG (Germany), ALung Technologies (United States), Microport Scientific (China), The Sorin Group (United States), Terumo Cardiovascular Group (United States) and Nipro Medical Corp (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Eurosets S.r.l. (Italy), ALung Technologies (United States), Medos Medizintechnik (Germany) and MAQUET Holding B.V. & Co. KG (Germany).
Segmentation Overview
AMA Research has segmented the market of Global ECMO Devices market by , Application (Neonatal, Pediatric and Adult) and Region.
On the basis of geography, the market of ECMO Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by End user , the sub-segment i.e. Hospitals will boost the ECMO Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mode, the sub-segment i.e. Portable (USCF) will boost the ECMO Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Modality, the sub-segment i.e. Veno-Venous (VV) will boost the ECMO Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technology Advancement regrading ECMO Devices
Market Growth Drivers:
Increasing Adoption of ECMO in Lung Transplantation Procedures and Rising Number of Cardiovascular and Growing Incidences of Chronic Obstructive Pulmonary Disorder
Challenges:
High Cost of ECMO Procedures and Lack of Skilled Professionals
Restraints:
Issue related to Complications Associated with ECMO
Opportunities:
Growing Demand from Emerging Economics such as China, India, among others and Increasing Survival Rates with ECMO and Rise in Geriatric Population
Market Leaders and their expansionary development strategies
In August 2023, Extracorporeal Life Support Organization (ELSO) and World Health Organization (WHO) has Partnered to improve access to ECMO therapy in low- and middle-income countries.
In June 2023, LivaNova introduced the Prosidio 3 Supraventricular Cannula, which is designed to minimize blood trauma and improve patient outcomes. Advanced Cannulae New cannulae designs were developed to improve blood flow and reduce the risk of complications associated with ECMO therapy.
Key Target Audience
ECMO Devices Companies, Research and Development Companies, Government Regulatory Authorities, Product Sales and Distribution Companies, Market Research and Consulting Firms and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.